Xmn1-158 γGVariant in B-Thalassemia Intermediate Patients in South-East of Iran.

Ebrahim Miri-Moghaddam, Sara Bahrami, Majid Naderi, Ali Bazi, Morteza Karimipoor

Open access · greenAbstract read

In one paragraph

Article in International journal of hematology-oncology and stem cell research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it

0cells of the map it votes in

5citing papers in PubMed

0.2field-weighted citation impact, top 50% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

Impact of Xmn1 polymorphism on hydroxyurea therapy in children with HbE-β non-transfusion dependent thalassemia: a cohort study.Clinical and experimental pediatrics · 2025
Article
The Effect of Xmn -1 Polymorphism and Coinheritance of Alpha Mutations on Age at First Blood Transfusion in Iranian Patients with Homozygote IVSI-5 Mutation.International journal of hematology-oncology and stem cell research · 2022
Article
Significance of genetic modifiers of hemoglobinopathies leading towards precision medicine.Scientific reports · 2021
Article
miR-30a regulates γ-globin expression in erythoid precursors of intermedia thalassemia through targeting BCL11A.Molecular biology reports · 2020
Article
Frequency of secondary modifiers in Beta Thalassemia intermedia in patients from Northern Punjab.Pakistan journal of medical sciences
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Ebrahim Miri-MoghaddamAssociate Professor, Genetics of Non-Communicable Disease Research Center, zahedan University of Medical Sciences, zahedan, Iran.

Sara BahramiMsc in Biology, Department of Biology, Payame Noor University, Zahedan, Iran.

Majid NaderiAssistant Professor, Genetics of Non-Communicable Diseases Research Center, Department of Pediatric Hematology & Oncology, Faculty of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran.

Ali BaziMsc in Hematology, Faculty of Allied Medical Sciences, Zabol University of Medical Sciences, Zabol, Iran.

Morteza KarimipoorPh.D, Molecular Medicine Department, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran.

Pasteur Institute of Iran · IRZabol University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hemoglobin FXmn-1 polymorphismβ-thalassemia intermediate

Identifiers

PMID28875012

PMCPMC5575729

OpenAlexW2562168793

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.